© BMJ Publishing Group Ltd. 2023
Editor-in-Chief: Professor Ananya Choudhury, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK
BMJ Oncology is an open access journal with a mission to optimise cancer care and improve patient outcomes. The journal prioritises high quality original research and review papers across the broad spectrum of cancer research, investigation, treatment and practice.
Interim Editor-in-Chief: James L. Gulley, MD, PhD, FACP, National Cancer Institute, National Institutes of Health, United States
The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the
Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
Editor-in-Chief: Pedro Ramirez, MD, Houston Methodist Hospital, Department of Obstetrics and
Gynecology
The International Journal of Gynecological Cancer (IJGC) is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. Its content is read by gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. IJGC emphasizes a multidisciplinary approach and includes original research, reviews, and video articles.
IJGC is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
BMJ
Oncology
JITC
Publishing in oncology?
IJGC
NEW LAUNCH!